5th Braunschweig International Symposium on Pharmaceutical Engineering Research
18–20 October 2023
18–20 October 2023
Dear colleagues, partners and friends,
on behalf of the Scientific Committee and the Center of Pharmaceutical Engineering I cordially invite scientists, researchers and professionals from industry, academia and research institutions to participate in the 5th International Symposium on Pharmaceutical Engineering Research – SPhERe. The conference will take place from October 18 – 20, 2023 in Braunschweig, Germany.
Prof. Dr.-Ing. Stephan Scholl
SPhERe addresses major issues on innovative methods and processes to develop and manufacture effective and customized drugs in a cost-efficient manner. Bringing together pharmacists, process and production engineers as well as microtechnologists from academia and industry, the conference will promote multidisciplinary exchange and collaboration.
The symposium is an excellent forum specially for young scientists to share and discuss important new developments and scientific advancements in pharmaceutical engineering and related fields.
Conference contributions are especially invited addressing – but are not limited to –
In particular, we would like to motivate young professionals to exchange ideas with colleagues from Europe and beyond to present their results in this multidisciplinary setting. For early career scientists the conference offers the chance to get in touch with advanced researchers who will provide insight into their different career paths. The best posters will be honoured with SPhERe Poster Awards.
KEYNOTE on Pharmaceutical Engineering
Keynote Lecture: How to bring API production to Germany? – Engineering Aspects
Speaker: Dr. Michael Häberl, Merck
Session I: API Synthesis
Invited Talk: New approaches for targeting the intracellular allosteric binding site of GPCRs Speaker: Dr. Matthias Schiedel,
Invited Talk: Manufacturing through plant cell culture technology – sustainable, controlled and flexible in scale
Speaker: Dr. Gilbert Gorr , PhytonBiotech
Session II: Scale-Up / Scale-Down Processes
Invited Talk: Towards sustainable continuous production of crystalline APIs
Speaker: Dr. Kerstin Wohlgemuth, TU Dortmund
Invited Talk: Digital formulation and process development of a directly compressed drug product
Speaker: Dr. Daniel Markl, University Strathclyde
POSTER SHORT TALKS & POSTER PARTY
KEYNOTE on Pharmaceutical Engineering
Keynote Lecture: Pharmaceutical engineering at nanoscale: Delivery of RNA and more
Speaker: Dr. Heinrich Haas, Universität Mainz
Session III: Solid Dosage Forms
Invited Talk: Material characterization in drug product development of oral solid dosage forms – an industry perspective
Speaker: Dr. Carolin Riehl, Merck
Session IV: Semi-Solid & Liquid Dosage Forms
Invited Talk: Current trends in dermal and transdermal drug delivery
Speaker: Prof. Dr. Jarmila Zbytovská,
Session V: Digital Models in Pharmaceutical
Invited Talk: Process analytical technologies for inline control of fluidized bed agglomeration using artificial intelligence
Speaker: Dr. Michael Jacob, Glatt GmbH
Special Guest Session
Speaker: Inga Benner, KoWi
Speaker: Kerstin Wohlgemuth, TU Dortmund
Speaker: Jhinuk Rahman-Yildir, NextPharma
Session VI: Analytics, PAT
Invited Talk: Benefits of using UV-Vis, NIR and Raman spectrometers as inline PAT in pharmaceutical applications
Speaker: Fuat Eker, ColVisTec
Session VII: Microsystems for Pharmaceutical Testing
Invited Talk: Droplet-based microfluidic screening: from basics to precision oncology
Speaker: Prof. Dr. Doris Heinrich, TU Ilmenau
SPhERe is dedicated to Pharmaceutical Engineering Research, an interdisciplinary field in which engineering and pharmacy join forces. The conference provides a unique opportunity for getting an overview of the state of research, addressing not only scientific but also practical challenges.
We thank all contributors for the submission of an abstract and will contact them shortly after review of the abstracts by the Scientific Committee. We are looking forward to meeting you at the 5th International SPhERE conference 2023.
The conference will cover the following topics
– but are not limited to –
Abstract submission and registration deadline:
31th July 2023. For registration deadline please refer to Dates to know.
The acceptance of the contributions will be based on the review of the abstracts by the Scientific Committee. Please note that your abstract will only be published in the conference volume if you accept the Open Access Consent by signature and upload of the signed document. Please note that the Center of Pharmaceutical Engineering will NOT make any changes or corrective action regarding the author information, so please make sure to check them accurately. Registration fee cannot be waived for presenting authors.
Abstracts of the SPhERe conference will be published in a conference volume. An electronic version of the conference volume will be provided to the participants. Additionally abstracts will published OPEN ACCESS by the library of TU Braunschweig. For including your abstract in the conference volume as well as for Open Access publication the organiser and the library need the written consent of the presenting author.
Your publications will be published in compliance with the applicable German copyright law, which means that the copyright remains with you. You only transfer the simple, unlimited right of use to Braunschweig University Library to reproduce, store, make the submitted publication publicly accessible on its servers. Please note that you may need to obtain the consent of co-authors for publishing. It is your responsibility to fulfill the copyright and exploitation rights of third parties.
Please use the Open Access Consent form and submit your signed written consent together with your abstract via the Online Abstract Submission.
Abstracts without written consent will not be published in the conference volume. There will will be no reminders to submit your written consent by the organisers.
The organiser additionally plans a SPhERe-related special issue in Pharmaceutics, an MDPI Open Access Journal. Upon abstract submission, please indicate your interest in publishing a regular paper (publication is subject to fees).
Length of the oral presentations:
Strict time keeping will be essential for the smooth running of the conference.
Please prepare your slides as a pptx file. In case you use special software for your presentation or if you have videos included into your file, please ask for a test run at the beginning of the conference.
Posters are scheduled for an introductory presentation in a separate session on Wednesday, 18th October 2023, followed by a poster party. Please note that your presentation time at the poster introduction is strictly limited to one slide and two minutes per poster.
The introductory presentation session will be followed by the poster party. This part of the conference will open with beer and snacks. Attendees will have the opportunity to learn about the authors’ poster research. All poster authors will be asked to remain at their poster and explain their work to the conference attendees.
The top three posters will be selected for a poster award.
Please upload your short poster introduction as a pptx/pdf file to the submission portal no later than 10th October. Presentations received after this date cannot be considered in the programme.
The poster presentation is an important facet of the scientific programme. The posters will be clustered and presented according to the final poster programme. We would like to motivate especially young scientists to submit an abstract for a poster presentation.
Poster size: A0
Poster format: Portrait.
Posters will be accessible throughout the conference.
Thank you for your interest in the 5th International Symposium on Pharmaceutical Engineering Research of the Center of Pharmaceutical Engineering which will be held from 18-20 October 2023.
Registration is open from 14th February until 15th September 2023. After your registration you receive a confirmation e-mail and an invoice including payment details. Please note special conditions for abstract submitters below.
|Participants from:||Early bird 2)||Late registration||2-Day Tickets 3)|
|Industry||550 EUR||600 EUR||480 EUR|
|ProPharm members industry||350 EUR||400 EUR||300 EUR|
|Academia||350 EUR||400 EUR||300 EUR|
|Doctoral candidates, students, accompanying persons 4)||190 EUR||240 EUR||not applicable|
1) Registration fees are net amounts. According to § 3a III Nr. 5 UStG the registration fee is to be calculated with 19% VAT. For participants from abroad, the service is only affected to a limited extent by the possibility of reversing the tax liability.
2) Early bird registration is possible until 25th August 2023.
3) There are two options for day tickets. Tickets are available from Wednesday to Thursday and from Thursday to Friday, respectively.
4) In order to obtain reduced access to the conference please send an electronic copy of your student card as a single PDF-file. Please use the online registration for submitting your student card copy.
The registration fee includes the conference ticket, an electronic conference volume, beverages, lunches, and conference dinner on 19th October 2023.
You will receive the invoice with payment confirmation after receipt of payment via the registration portal.
Under the following link you find a list of hotels.
Cancellations will only be accepted in written form. In case of no-show the conference fees won’t be refunded and fees not yet paid still have to be paid. If the event is cancelled by the Center of Pharmaceutical Engineering the registration fees for the conference will be refunded. Further claims for compensation are excluded.
To get an impression of previous SPhERe conferences please screen the information of the years 2015, 2017, 2019 and 2023. Open access publications of SPhERe 2019, 2021 and 2023 are summarized in the conference proceedings.
All photos by Marisol Glasserman / TU Braunschweig
All photos by Marisol Glasserman Marcel Schrader, Karl Vorländer, Andrea Mildner/ TU Braunschweig
All photos by Justine Anders/Zentrum für Pharmaverfahrenstechnik/TU Braunschweig
Venue: TU Braunschweig, Center of Pharmaceutical Engineering, Franz-Liszt-Str. 35a, 38106 Braunschweig
Date: 18 – 20 October 2023
Center of Pharmaceutical Engineering
Prof. Dr.-Ing. Stephan Scholl
Prof. Ludger Beerhues, TU Braunschweig
Dr. Gerlinde Benninger, TU Braunschweig
Prof. Heike Bunjes, TU Braunschweig
Prof. Andreas Dietzel, TU Braunschweig
Prof. Arno Kwade, TU Braunschweig
Prof. Stephan Scholl, TU Braunschweig
JProf. Denise Steiner, University of Tübingen
PD Dr. Kerstin Wohlgemuth, TU Dortmund University
Technische Universität Braunschweig
Zentrum für Pharmaverfahrenstechnik (PVZ)
Technische Universität Braunschweig is a statutory corporation. The PVZ with its SPhERe conference website is legally represented at a decentralized server by Prof. Dr.-Ing. Arno Kwade.
Ministry for Science and Culture of Lower Saxony
EU VAT number:
Responsibility under the German Press Law §55 Sect. 2 RStV
Zentrum für Pharmaverfahrenstechnik (PVZ)
Managing Director Dr. Gerlinde Benninger
The district court of Hamburg ruled that, when a link is included, co-responsibility may exist for the contents of the linked pages. According to the court’s ruling, this can only be avoided by expressly dissociating oneself from these contents. For this reason, we have drafted the following liability rules.
Data protection declaration
The Technical University Carolo-Wilhelmina at Brunswick, hereafter TU, declares the following:
The TU does not guarantee the correctness, completeness or quality of the information provided. TU cannot take responsibility regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect. Liability claims will therefore be rejected.
All offers are not-binding and without obligation. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the TU without notice.
Referrals and links
TU is not responsible for any contents linked or referred to from his pages – unless the author has full knowledge of illegal contents and would be able to prevent the visitors of his site from viewing those pages. If any damage occurs by the use of information presented there, only the author of the respective pages might be liable, not the one who has linked to these pages. Furthermore the author is not liable for any postings or messages published by users of discussion boards, guestbooks or mailinglists provided on his page.
TU intends not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object.
The copyright for any material created by the author is reserved. Any duplication or use of objects such as diagrams, sounds or texts in other electronic or printed publications is not permitted without the author’s agreement. This rule does not apply to press releases.
If the opportunity for the input of personal or business data (email addresses, name, addresses) is given, the input of these data is voluntarily. The use of all services offered is permitted – if and so far technically possible and reasonable – without specification of any personal data or under specification of anonymized data or an alias.
Legal validity of this disclaimer
If sections or individual terms of this statement are not legal or correct, the content or validity of the other parts remain uninfluenced by this fact.